Wednesday, February 16, 2022
Study Shows New Drug Combination More Effective Against SARS-CoV-2
Researchers at the University of Maryland School of Medicine (UMSOM) and University of Pennsylvania Perelman School of Medicine have identified a powerful combination of antivirals to treat COVID-19. The researchers showed that combining the experimental drug brequinar with either of the two drugs already approved by the U.S. Food and Drug Administration for emergency use, remdesivir or molnupiravir, inhibited growth of the SARS-CoV-2 virus in human lung cells and in mice. Their findings suggest that these drugs are more potent when used in combination than individually.
Tuesday, February 15, 2022
UM School of Medicine Awarded $1.87 Million Grant to Increase Diversity in Genetic Counseling Programs
University of Maryland School of Medicine (UMSOM) faculty members in the Master’s in Genetic Counseling (MGC) Training Program have been awarded a $1.87 million grant from the Warren Alpert Foundation (WAF) to recruit and retain genetic counseling students from diverse backgrounds, both at the level of incoming students and as practicing genetic counselors.
Tuesday, February 15, 2022
Multi-Country African Research Reports High Rates of COVID-19-Related Deaths Among Hospitalized Children and Adolescents
African children and adolescents hospitalized with COVID-19 experience much higher mortality rates than Europeans or North Americans of the same age, according to a recently published study conducted by researchers from the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) and the Institute of Human Virology Nigeria (IHVN). Both organizations are members of the Global Virus Network (GVN).
Monday, February 14, 2022
UM School of Medicine Launches Major New Center Focused on Advanced Research Training and Innovation
University of Maryland, Baltimore (UMB) President Bruce Jarrell, MD, announced today the official launch of an innovative new University of Maryland School of Medicine (UMSOM) Center that will focus on inspiring, growing and developing the next generation of clinician-scientists and biomedical research-scientists who will advance high-impact research and discovery.
Wednesday, February 02, 2022
ADHD Medicine May Treat Symptoms of Genetic Movement Disorder in Children, University of Maryland School of Medicine Study Finds
Using a common attention deficit hyperactivity disorder (ADHD) medication appears to help manage the symptoms of a rare and currently difficult to treat genetic movement disorder primarily found in children, according to a new study from a University of Maryland School of Medicine (UMSOM) researcher Andrea Meredith, PhD, and her collaborators.
Tuesday, February 01, 2022
Study: Losing Excess Weight in Adulthood Reduces Risk of Developing Polyps that can Lead to Colorectal Cancer
Weight loss for adults, particularly those who are overweight or obese, may reduce their risk of developing a type of polyp that can lead to colorectal cancer, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM). Findings were published today in the journal JNCI Cancer Spectrum.
Monday, January 31, 2022
New Technique Consistently Works to Open Blood-Brain Barrier, Paving Way for Pre-Clinical Studies of Neurologic Drugs
University of Maryland School of Medicine researchers developed a technique in laboratory animals to consistently and reproducibly open the blood-brain barrier. This barrier serves as a barricade securing the brain from the external world blocking out certain environmental toxins, but also prevents drug therapies from reaching their intended targets. The new technique is based on a routine procedure for removing clots from the brain’s arteries in patients. This advancement was conducted by Piotr Walczak, MD, PhD, Professor of Diagnostic Radiology and Nuclear Medicine at the University of Maryland School of Medicine, and Miroslaw Janowski, MD, PhD, Associate Professor of Diagnostic Radiology and Nuclear Medicine at the University of Maryland School of Medicine.
Thursday, January 27, 2022
16th Annual Medical Student Auction Supports Fight Against Food Insecurity
In keeping with tradition since 2006, the University of Maryland School of Medicine (UMSOM) Class of 2024 Student Government has organized this year’s Annual Second-Year Medical Student Auction. A portion of the proceeds will be donated to Bmore Community Food, an organization committed to serving the vulnerable and marginalized population in Baltimore City who are experiencing food insecurity. The remaining funds will support the Class of 2024 medical student activities.
Thursday, January 27, 2022
Microbiome of Mother’s Vagina May Affect Infant Mortality Risk and Baby’s Development
A new study in mice from University of Maryland School of Medicine researchers showed that an unhealthy vaginal microbiome in pregnant mothers in combination with an unhealthy diet contributed to increased pup deaths and altered development in the surviving babies.
Wednesday, January 26, 2022
Trial Co-led by University of Maryland School of Medicine Scientist Confirms Safety of “Mix-and-Match” COVID-19 Vaccine Booster Dosing
A University of Maryland School of Medicine (UMSOM), Center for Vaccine Development and Global Health (CVD), expert is co-leading an ongoing study that was pivotal in recommending adults and teens receive booster COVID-19 shots of their choosing starting in fall 2021. The preliminary clinical trial results, reported today in The New England Journal of Medicine, found that is safe and effective to receive boosters that are the same or a different one from the person’s primary vaccine(s).